Zydus Lifesciences1131.50
-11.50 (-1.01%)

Zydus Lifesciences Share Price

1131.50-11.50 (-1.01%)
+12.23% past 1 Year

Zydus Lifesciences is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating (research & development), manufacturing, marketing and selling of

Corporate filings & documents

Announcements

Transcript of the 31st Annual General Meeting
3 days ago
Transcript of the 31st Annual General Meeting
3 days ago
Zydus Announces Positive Topline Results from Completed EVIDENCES-X Phase II(b) Clinical Trial of Saroglitazar Mg in MASH.
4 days ago
Zydus Announces Positive Topline Results from Completed EVIDENCES-X Phase II(b) Clinical Trial of Saroglitazar Mg in MASH.
4 days ago
Incorporation of a wholly owned subsidiary in Gift City Gandhinagar Gujarat
1 week ago
Incorporation of a wholly owned subsidiary in Gift City Gandhinagar Gujarat
1 week ago
ESG Rating
1 week ago
ESG Rating
1 week ago
Disclosure under SEBI (Prohibition of Insider Trading) Regulations 2015
1 week ago
Disclosure under SEBI (Prohibition of Insider Trading) Regulations 2015
1 week ago
Investor Presentation
1 week ago
Investor Presentation
1 week ago
ESG Rating
1 week ago
ESG Rating
1 week ago
Zydus announces final approval from the USFDA for Ascorbic Acid Injection with 180-Days CGT exclusivity.
1 week ago
Zydus announces final approval from the USFDA for Ascorbic Acid Injection with 180-Days CGT exclusivity.
1 week ago
Transcript of the post results earnings call held on August 11 2026
2 weeks ago
Transcript of the post results earnings call held on August 11 2026
2 weeks ago
The management of the Company will meet the investors in Singapore and Hong Kong between August 24 2026 to August 26 2026 in the form of a Non-Deal Roadshow (NDR).
2 weeks ago
The management of the Company will meet the investors in Singapore and Hong Kong between August 24 2026 to August 26 2026 in the form of a Non-Deal Roadshow (NDR).
2 weeks ago
Update on Investor Conference
3 weeks ago
Update on Investor Conference
3 weeks ago
Newspaper cutting with regard to publication of unaudited financial results for the quarter ended on June 30 2026 in Financial Express on August 12 2026.
3 weeks ago
Newspaper cutting with regard to publication of unaudited financial results for the quarter ended on June 30 2026 in Financial Express on August 12 2026.
3 weeks ago
Regulation 44(3) disclosure of AGM 2026
3 weeks ago
Regulation 44(3) disclosure of AGM 2026
3 weeks ago
Change in Directors
3 weeks ago
Change in Directors
3 weeks ago
Scrutinizers report
3 weeks ago
Scrutinizers report
3 weeks ago
Outcome of AGM
3 weeks ago
Outcome of AGM
3 weeks ago
Audio Link of the Investor Call held on August 11 2026
3 weeks ago
Audio Link of the Investor Call held on August 11 2026
3 weeks ago
Reporting of violation of Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations 2015
3 weeks ago
Reporting of violation of Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations 2015
3 weeks ago
Press Release
3 weeks ago
Press Release
3 weeks ago
Press Release
3 weeks ago
Press Release
3 weeks ago
Investor Presentation
3 weeks ago
Investor Presentation
3 weeks ago
Unaudited financial results for the quarter ended on June 30 2026
3 weeks ago
Unaudited financial results for the quarter ended on June 30 2026
3 weeks ago
Unaudited financial results for the quarter ended on June 30 2026
3 weeks ago
Unaudited financial results for the quarter ended on June 30 2026
3 weeks ago
Zydus launches REVAHALE Indias first once-daily nebulised LAMA for COPD.
3 weeks ago
Zydus launches REVAHALE Indias first once-daily nebulised LAMA for COPD.
3 weeks ago
The Company is going to participate in Motilal Oswal 22nd Annual Global Investor Conference 2026 on August 18 2026.
3 weeks ago
The Company is going to participate in Motilal Oswal 22nd Annual Global Investor Conference 2026 on August 18 2026.
3 weeks ago

Concalls & investor presentations

May 2026
Feb 2026
ConcallPresentation
Feb 2026
Nov 2025
ConcallPresentation
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation

Corporate Actions

Date
Type
Details
2026-07-24
Dividend
1.0
2025-07-25
Dividend
11.0
2024-07-26
Dividend
3.0
2023-07-28
Dividend
6.0
2022-07-28
Dividend
2.5

Company details

Registered office

Zydus Corporate Park, Scheme No.63 Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle Sarkhej - Gandhinagar Highway Ahmedabad Gujarat PIN: 382481 Tel No: 079-71800000 / 48040000 Fax No: 079-48040000 Email: [email protected] Internet: www.zyduscadila.com

Registrars

506-508, 5th Floor, Amaranth Business Complex - I (ABC - I)Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura, Ahmedabad - 380009 506-508, 5th Floor, Amaranth Business Complex - I (ABC - I) Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road Navrangpura PIN: Tel No: NULL Fax No: NULL Email: [email protected] Internet: https://in.mpms.mufg.com/

Management

Dhaval N Soni, Company Secretary & Compliance Officer

Pankaj R Patel, Chairman

Bhadresh K Shah, Non Executive Independent Director

Shelina P Parikh, Non Executive Independent Woman Director

Akhil Monappa, Non Executive Independent Director

Upasana Konidela, Non Executive Independent Woman Director

Kulin S Lalbhai, Non Executive Independent Director

Sharvil P Patel, Managing Director

Mukesh M Patel, Non Independent & Non Executive Director

Ganesh N Nayak, Non Executive Director

Details

BSE 532321

NSE ZYDUSLIFE

ISIN INE010B01027

Zydus Lifesciences Ltd Share Price Today

The Zydus Lifesciences Ltd share price today is ₹1,141.10. During the trading session, the Zydus Lifesciences Ltd share price opened at ₹1,154.20 and recorded an intraday high of ₹1,157.80 and a low of ₹1,138.60. Last closing price was ₹1,154.20. Over the past 52 weeks, the Zydus Lifesciences Ltd share price has ranged between ₹835.50 and ₹1,205.00. The current Zydus Lifesciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.